AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25862566 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (younger than 75 years)
Number of subjects: 685
Study 23238910 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis plans facilitated by patient advocates (PACP)
Number of subjects: 0
Study 23238910 — intervention group
Group type: COMPARATOR
Intervention: Crisis plans drawn up by clinicians (CCP)
Number of subjects: 0
Study 22227184 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of antioxidants in CKD patients
Number of subjects: 185
Study 22227184 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidative stress measured in blood
Number of subjects: 185
Study 22227184 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient monitoring
Number of subjects: 185
Study 19809786 — intervention group
Group type: COMPARATOR
Intervention: Gamma Knife Model 4C (group 4C)
Number of subjects: 78
Study 19809786 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma Knife Perfexion (group P2)
Number of subjects: 78
Study 17600880 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin and etoposide with ondansetron and metoclopramide
Number of subjects: 60
Study 17600880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin and etoposide with ondansetron, metoclopramide plus dexamethasone 8 mg i.v. per day for 3 days
Number of subjects: 60
Study 17249630 — intervention group
Group type: EXPERIMENTAL
Intervention: DSM-IV model for classifying depressive disorders
Number of subjects: 0
Study 12746908 — intervention group
Group type: EXPERIMENTAL
Intervention: Active lupus nephritis patients
Number of subjects: 45
Study 12746908 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactive lupus disease patients
Number of subjects: 45
Study 12746908 — intervention group
Group type: COMPARATOR
Intervention: Parapemphigus controls
Number of subjects: 45
Study 12746908 — intervention group
Group type: COMPARATOR
Intervention: Diabetes controls
Number of subjects: 45
Study 10891035 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 40
Study 10891035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8929200 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% CO2 exposure
Number of subjects: 10
Study 1530141 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (80 mg, 160 mg)
Number of subjects: 16
Study 1530141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg, 20 mg)
Number of subjects: 16
Study 1530141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 4004014 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 16
Study 4004014 — intervention group
Group type: COMPARATOR
Intervention: No acetazolamide (Control)
Number of subjects: 16
Study 30084949 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped wedge design (SWD) intervention for post-partum intra-uterine device insertion services
Number of subjects: 0
Study 29774635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 2 mg/day
Number of subjects: 135
Study 29774635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 6-12 mg/day
Number of subjects: 135
Study 29774635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 24-30 mg/day
Number of subjects: 135
Study 29774635 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (OLE, initial dose: 2 mg/day, maintenance dose: 6-24 mg/day, max 30 mg/day)
Number of subjects: 135
Study 26571136 — intervention group
Group type: EXPERIMENTAL
Intervention: Zumba® fitness (1 to 2 classes of 1 hour weekly)
Number of subjects: 20
Study 26571136 — intervention group
Group type: COMPARATOR
Intervention: Maintenance of habitual activity (control group)
Number of subjects: 20
Study 23867053 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 66
Study 23867053 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial intervention
Number of subjects: 66
Study 22853755 — intervention group
Group type: EXPERIMENTAL
Intervention: V-5 Immunitor™ (V5)
Number of subjects: 123
Study 22853755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 20538830 — intervention group
Group type: EXPERIMENTAL
Intervention: Bachmann's bundle pacing
Number of subjects: 30
Study 20538830 — intervention group
Group type: COMPARATOR
Intervention: Right atrial appendage pacing
Number of subjects: 30
Study 18675745 — intervention group
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block
Number of subjects: 28
Study 18675745 — intervention group
Group type: COMPARATOR
Intervention: Superficial cervical plexus block plus general anesthesia
Number of subjects: 28
Study 15902992 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (4 x 5 g/d for 5 days)
Number of subjects: 18
Study 14602495 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical surgery followed by post-operative radiation therapy (Sx+PORT) (Arm I)
Number of subjects: 72
Study 14602495 — intervention group
Group type: COMPARATOR
Intervention: Radical radiation therapy followed by salvage surgery (RRT+/‐SSx) (Arm II)
Number of subjects: 72
Study 10485502 — intervention group
Group type: EXPERIMENTAL
Intervention: DFP 25 mg
Number of subjects: 196
Study 10485502 — intervention group
Group type: EXPERIMENTAL
Intervention: DFP 50 mg
Number of subjects: 196
Study 10485502 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 550 mg
Number of subjects: 196
Study 10485502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 8734768 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN) at doses of 0.015, 0.25, 1.0, 2.0 micrograms/kg/min for 20 min each
Number of subjects: 12
Study 8734768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1744874 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% polynoxylin powder applied daily to the groin and external genitalia
Number of subjects: 100
Study 1744874 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 100
Study 6803377 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antibiotics (neomycin and polymyxin)
Number of subjects: 54
Study 6803377 — intervention group
Group type: COMPARATOR
Intervention: Topical antibiotics (neomycin and polymyxin) plus systemic antibiotics (gentamicin and penicillin)
Number of subjects: 54
Study 28797212 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless Learning (EL)
Number of subjects: 24
Study 28797212 — intervention group
Group type: COMPARATOR
Intervention: Trial-and-Error Learning (TEL)
Number of subjects: 24
Study 28797212 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual cues
Number of subjects: 24
Study 28797212 — intervention group
Group type: EXPERIMENTAL
Intervention: Lexical cues
Number of subjects: 24
Study 27519933 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% tropicamide and 5% phenylephrine eyedrops (PTT regimen)
Number of subjects: 30
Study 27519933 — intervention group
Group type: COMPARATOR
Intervention: 0.5% tropicamide eyedrops (TTT regimen)
Number of subjects: 30
Study 26598195 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA pretreatment followed by self-etching resin adhesive
Number of subjects: 12
Study 26598195 — intervention group
Group type: COMPARATOR
Intervention: Self-etching resin adhesive only (Control)
Number of subjects: 12
Study 23010696 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Internet
Number of subjects: 0
Study 23010696 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Internet
Number of subjects: 0
Study 23010696 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Internet+Phone
Number of subjects: 0
Study 21463114 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab maintenance (one weekly injection for 4 weeks)
Number of subjects: 269
Study 21463114 — intervention group
Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 269
Study 18645555 — intervention group
Group type: EXPERIMENTAL
Intervention: With dressing (dressing change and re-application every two days)
Number of subjects: 102
Study 18645555 — intervention group
Group type: COMPARATOR
Intervention: Without dressing (wound left open after first dressing change at 48 hours)
Number of subjects: 102
Study 16278926 — intervention group
Group type: EXPERIMENTAL
Intervention: Azantac
Number of subjects: 25
Study 16278926 — intervention group
Group type: EXPERIMENTAL
Intervention: Midaven
Number of subjects: 25
Study 12782431 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO 10,000 U three times weekly
Number of subjects: 122
Study 12782431 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment
Number of subjects: 122
Study 10634391 — intervention group
Group type: EXPERIMENTAL
Intervention: Men during exercise
Number of subjects: 16
Study 10634391 — intervention group
Group type: COMPARATOR
Intervention: Women during exercise
Number of subjects: 16
Study 9471024 — intervention group
Group type: EXPERIMENTAL
Intervention: O1COr (Omeprazole 20 mg once daily + Clarithromycin 250 mg twice daily + Ornidazole 500 mg twice daily)
Number of subjects: 203
Study 9471024 — intervention group
Group type: EXPERIMENTAL
Intervention: OCOr (Omeprazole 20 mg twice daily + Clarithromycin 250 mg twice daily + Ornidazole 500 mg twice daily)
Number of subjects: 203
Study 9471024 — intervention group
Group type: COMPARATOR
Intervention: OCM (Omeprazole 20 mg twice daily + Clarithromycin 250 mg twice daily + Metronidazole 500 mg twice daily)
Number of subjects: 203
Study 1610161 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice Bubbles (0.5 g/kg body weight)
Number of subjects: 7
Study 1610161 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustain (0.5 g/kg body weight)
Number of subjects: 7
Study 1610161 — intervention group
Group type: EXPERIMENTAL
Intervention: All‐Bran (0.5 g/kg body weight)
Number of subjects: 7
Study 1610161 — intervention group
Group type: EXPERIMENTAL
Intervention: Porridge (0.5 g/kg body weight)
Number of subjects: 7
Study 1610161 — intervention group
Group type: EXPERIMENTAL
Intervention: White bread (0.5 g/kg body weight)
Number of subjects: 7
Study 1610161 — intervention group
Group type: COMPARATOR
Intervention: Egg and bacon meal (0.5 g protein/kg body weight)
Number of subjects: 7
Study 3884747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cisplatin (greater than 100 mg/m2) by an eight-hour infusion
Number of subjects: 20
Study 3884747 — intervention group
Group type: COMPARATOR
Intervention: High-dose cisplatin (greater than 100 mg/m2) by a one-hour infusion
Number of subjects: 20
Study 31103608 — intervention group
Group type: EXPERIMENTAL
Intervention: Metreleptin administration (replacement doses)
Number of subjects: 29
Study 31103608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31103608 — intervention group
Group type: EXPERIMENTAL
Intervention: Metreleptin administration (escalating doses)
Number of subjects: 29
Study 31103608 — intervention group
Group type: COMPARATOR
Intervention: Placebo (hypoleptinemic state)
Number of subjects: 29
Study 29349511 — intervention group
Group type: EXPERIMENTAL
Intervention: iPAPD+SRP
Number of subjects: 24
Study 29349511 — intervention group
Group type: COMPARATOR
Intervention: sham-treatment+SRP
Number of subjects: 24
Study 26406219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical stabilization exercise (5 weeks)
Number of subjects: 24
Study 26406219 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study 26225780 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Nepafenac
Number of subjects: 200
Study 26225780 — intervention group
Group type: COMPARATOR
Intervention: 0.4% Ketorolac Tromethamine
Number of subjects: 200
Study 26225780 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% Nepafenac (Diabetic subgroup)
Number of subjects: 200
Study 24125085 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused condition (n = 45)
Number of subjects: 124
Study 24125085 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental sexual schema-focused condition (n = 37)
Number of subjects: 124
Study 24125085 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 42)
Number of subjects: 124
Study 24125085 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall dropout rate
Number of subjects: 124
Study 24125085 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of dropout
Number of subjects: 124
Study 21172477 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimized cardiopulmonary bypass (MCPB)
Number of subjects: 37
Study 21172477 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation (CCPB)
Number of subjects: 37
Study 19088658 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual ED
Number of subjects: 30
Study 19088658 — intervention group
Group type: COMPARATOR
Intervention: PS
Number of subjects: 30
Study 16563329 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapiscope
Number of subjects: 40
Study 16563329 — intervention group
Group type: COMPARATOR
Intervention: Chest auscultation
Number of subjects: 40
Study 12467721 — intervention group
Group type: EXPERIMENTAL
Intervention: New irregularity index algorithm
Number of subjects: 40
Study 12467721 — intervention group
Group type: COMPARATOR
Intervention: Clinical evaluation by dermatologists
Number of subjects: 40
Study 11460456 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended ambulatory physiotherapy (EAP)
Number of subjects: 35
Study 11460456 — intervention group
Group type: COMPARATOR
Intervention: Regular physiotherapy (PT)
Number of subjects: 35
Study 9676677 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific instructions about abstract accuracy (intervention group)
Number of subjects: 250
Study 9676677 — intervention group
Group type: COMPARATOR
Intervention: No specific instructions (control group)
Number of subjects: 250
Study 9676677 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of defects
Number of subjects: 250
Study 9676677 — intervention group
Group type: EXPERIMENTAL
Intervention: Defective abstracts analysis
Number of subjects: 250
Study 7973228 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 3131794 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine-vasopressin (AVP)
Number of subjects: 0
Study 3131794 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 0
Study 3131794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31230964 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) (45 L/min, FIO2 100%)
Number of subjects: 90
Study 31230964 — intervention group
Group type: COMPARATOR
Intervention: High-Flow Face Mask (HFFM) (15 L/min)
Number of subjects: 90
Study 29219895 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RES)
Number of subjects: 21
Study 29219895 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 21
Study 28759977 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive backward body weight‐supported treadmill training
Number of subjects: 30
Study 28759977 — intervention group
Group type: COMPARATOR
Intervention: General treadmill gait training (control)
Number of subjects: 30
Study 26148997 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hepatectomy (LH)
Number of subjects: 100
Study 26148997 — intervention group
Group type: COMPARATOR
Intervention: Open hepatectomy (OH)
Number of subjects: 100
Study 23331421 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 15
Study 23331421 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol
Number of subjects: 15
Study 23331421 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study 22029547 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 week stepped activity programme (activity diary, dance DVD, circuit-training, motivational interviewing)
Number of subjects: 396
Study 22029547 — intervention group
Group type: COMPARATOR
Intervention: Control schools (not specified in detail)
Number of subjects: 396
Study 19395275 — intervention group
Group type: EXPERIMENTAL
Intervention: ClosureFAST (RF thermal ablation)
Number of subjects: 69
Study 19395275 — intervention group
Group type: COMPARATOR
Intervention: 980-nm EVL (endovenous laser ablation)
Number of subjects: 69
Study 16894099 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 333
Study 16894099 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 333
Study 16894099 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 333
Study 16894099 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 333
Study 15315998 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy and exercise training (n = 46)
Number of subjects: 90
Study 15315998 — intervention group
Group type: COMPARATOR
Intervention: Home exercise (control condition; n = 44)
Number of subjects: 90
Study 11293458 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmentation of videos into coarse and fine units with simultaneous description
Number of subjects: 0
Study 11293458 — intervention group
Group type: EXPERIMENTAL
Intervention: Describing from memory rather than perception
Number of subjects: 0
Study 11293458 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptions were telegraphic and without communicative intent
Number of subjects: 0
Study 9471092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention involving teaching refusal skills to adolescents
Number of subjects: 2000
Study 9471092 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 2000
Study 7932336 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with dyspeptic cholelithiasis (Group 2)
Number of subjects: 48
Study 7932336 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with dyspepsia after cholecystectomy (Group 4)
Number of subjects: 48
Study 7932336 — intervention group
Group type: COMPARATOR
Intervention: Patients with no dyspepsia after cholecystectomy (Group 3)
Number of subjects: 48
Study 30810638 — intervention group
Group type: EXPERIMENTAL
Intervention: GTP (periodontal and peri-implant maintenance therapy)
Number of subjects: 80
Study 30810638 — intervention group
Group type: COMPARATOR
Intervention: GNTP (no regular maintenance)
Number of subjects: 80
Study 30190749 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability exercise
Number of subjects: 62
Study 30190749 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise
Number of subjects: 62
Study 26595937 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise intervention
Number of subjects: 238
Study 26595937 — intervention group
Group type: EXPERIMENTAL
Intervention: GLTEQ scores
Number of subjects: 238
Study 24279801 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 32
Study 24279801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 22596206 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 49
Study 22596206 — intervention group
Group type: COMPARATOR
Intervention: THC
Number of subjects: 49
Study 22596206 — intervention group
Group type: EXPERIMENTAL
Intervention: THC with olanzapine
Number of subjects: 49
Study 20557509 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigonometric method (TM) of radiographic analysis
Number of subjects: 51
Study 20557509 — intervention group
Group type: COMPARATOR
Intervention: Goniometer method (GM)
Number of subjects: 51
Study 17707091 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulatory therapy
Number of subjects: 130
Study 17707091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 15943840 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg twice daily
Number of subjects: 54
Study 15943840 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 54
Study 15943840 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 54
Study 15943840 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine and Omeprazole
Number of subjects: 54
Study 12808175 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysulphone filter HD
Number of subjects: 12
Study 12808175 — intervention group
Group type: COMPARATOR
Intervention: Cuprophane filter HD
Number of subjects: 12
Study 10492157 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg daily for 2 days)
Number of subjects: 10
Study 10492157 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (150 mg daily for 21 days)
Number of subjects: 10
Study 8697718 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial cooling
Number of subjects: 45
Study 8697718 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-hold in expiration combined with facial cooling
Number of subjects: 45
Study 1766707 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 89
Study 1766707 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus vancomycin
Number of subjects: 89
Study 6752878 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirprofen 200 mg four times a day
Number of subjects: 342
Study 6752878 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 900 mg four times a day
Number of subjects: 342
Study 6752878 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirprofen
Number of subjects: 342
Study 6752878 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 342
Study 31433895 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided dorsal penile nerve block
Number of subjects: 33
Study 31433895 — intervention group
Group type: COMPARATOR
Intervention: Neurostimulator-guided pudendal nerve block
Number of subjects: 33
Study 29929495 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief multifamily psychoeducation (BMP)
Number of subjects: 49
Study 29929495 — intervention group
Group type: COMPARATOR
Intervention: Control group (one counseling session administered by a nurse)
Number of subjects: 49
Study 27543828 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Goal Intervention (OGI)
Number of subjects: 25
Study 27543828 — intervention group
Group type: COMPARATOR
Intervention: Craft activities (control)
Number of subjects: 25
Study 25251794 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 30
Study 25251794 — intervention group
Group type: COMPARATOR
Intervention: No massage (control)
Number of subjects: 30